Background: The adhesion molecule L-selectin is expressed on the cell
surface of lymphocytes and mediates their migration from the bloodstre
am into lymph nodes. L-selectin is able to recognize four glycoprotein
ligands, three of which - Sgp50, Sgp90 and Sgp200 - are sulphated, bi
nd specifically to L-selectin and are synthesized by the high endothel
ial venules of the peripheral and mesenteric lymph nodes. One of these
three sulphated L-selectin ligands, Sgp90, has been shown to be ident
ical to the known surface marker CD34 and is expressed on the cell sur
face of endothelial cells. The cDNA encoding Sgp50 has been cloned, an
d its product, which has been designated GlyCAM-1, is secreted. The th
ird ligand, Sgp200, is both secreted and cell-associated. We have inve
stigated how the expression of these sulphated glycoproteins is regula
ted during an immune response. Results: Here we demonstrate that, duri
ng a primary immune response, the expression and secretion of both Gly
CAM-1 and Sgp200 are reduced, recovering to normal levels 7-10 days af
ter antigen stimulation. In contrast, the expression of cell-associate
d CD34 and Sgp200 is relatively unaffected. These results may account
for the modest decreases in the binding of an L-selectin-IgG fusion pr
otein to high endothelial venules of inflamed peripheral lymph nodes t
hat have been observed after antigen exposure. In vivo experiments sho
w that, following the decrease in the levels of secreted GlyCAM-1 and
Sgp200, migration of lymphocytes from the blood stream into lymph node
s remains L-selectin-dependent, but more lymphocytes home to antigen-p
rimed than unprimed peripheral lymph nodes. Conclusions: We suggest th
at the secreted forms of the L-selectin ligands GlyCAM-1 and Sgp200 ac
t as modulators of cell adhesion, and that cell-associated CD34 and Sg
p200 are the ligands that mediate the initial loose binding of lymphoc
ytes to high endothelial venules.